Current Issue


Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare

A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.

Register now for next ACP, Annals of Internal Medicine forum on COVID-19

On Oct. 8, panelists will provide insight on the clinical implications of the immunology of SARS-CoV-2 and the COVID-19 vaccine, including the status of booster doses and the efficacy of vaccination in various groups.

MKSAP Quiz: Enlarging, painful inguinal lymph node

A 56-year-old man is evaluated for an enlarging, painful inguinal lymph node he first noticed 1 month ago. He has a history of follicular lymphoma of 8 years' duration. Following a physical exam, lab tests, and PET/CT scan, what is the most appropriate management?

Adding an antihypertensive to existing regimens associated with greater BP reduction than maximizing dose, with some caveats in adherence

A retrospective study of older veterans with hypertension found that while adding a medication reduced systolic blood pressure by an extra point, patients who received a dose increase instead of a new drug were more likely to maintain the regimen.

Menopausal hormone therapy not associated with increased dementia risk

The findings of this retrospective study in the United Kingdom should reassure women taking menopausal hormonal therapy but do not support its use to prevent dementia, a linked opinion piece said.

ACP's Tech Hub hosts webinar on reducing cognitive burden in primary care with artificial intelligence

The webinar on Oct. 12 will cover the revolutionary impact artificial intelligence can have on diagnosis and care, physician satisfaction, revenue, and value-based outcomes.

And the winner is …

ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.